How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support

被引：0
|
作者：
Maurice J. Berkowitz
Carlie K. Thompson
Laura T. Zibecchi
Minna K. Lee
Elani Streja
Jacob S. Berkowitz
Cachet M. Wenziger
Jennifer L. Baker
Maggie L. DiNome
Deanna J. Attai
机构：
[1] University of California Los Angeles,Department of Medicine, David Geffen School of Medicine
[2] University of California Los Angeles,Department of Surgery, David Geffen School of Medicine
[3] University of California Los Angeles,Department of Nursing
[4] University of California Irvine School of Medicine,Department of Medicine
[5] University of Pittsburgh,Dietrich School of Arts and Sciences
[6] UCLA Health Burbank Breast Care,undefined
来源：
Journal of Cancer Survivorship | 2021年 / 15卷
关键词：
Breast cancer; Endocrine therapy; Tamoxifen; Side effects; Aromatase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：29 / 39
页数：10
相关论文
共 50 条
  • [31] ENDOCRINE EFFECTS OF TAMOXIFEN THERAPY IN BREAST-CANCER PATIENTS
    DNISTRIAN, AM
    DILLON, HJ
    FRACCHIA, AA
    GREENBERG, EJ
    HAKES, TB
    KAUFMAN, RJ
    CURRIE, VE
    SCHWARTZ, MK
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 112 - 112
  • [32] Breast cancer endocrine therapy adherence in health professional shortage areas: Unique effects on patients with mental illness
    Haskins, Cole B.
    McDowell, Bradley D.
    Carnahan, Ryan M.
    Fiedorowicz, Jess G.
    Wallace, Robert B.
    Smith, Brian J.
    Chrischilles, Elizabeth A.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2021, 140
  • [33] The Effects of Expressing Religious Support Online for Breast Cancer Patients
    Mclaughlin, Bryan
    Yang, JungHwan
    Yoo, Woohyun
    Shaw, Bret
    Kim, Soo Yun
    Shah, Dhavan
    Gustafson, David
    HEALTH COMMUNICATION, 2016, 31 (06) : 762 - 771
  • [34] Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence
    Ibrar, Maryam
    Peddie, Nicola
    Agnew, Sommer
    Diserholt, Amanda
    Fleming, Leanne
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [35] Adjuvant Endocrine Therapy adherence in Breast Cancer patients and the Brazilian National Health System
    Herrera, Ana Cristina
    Kasai, Caio C.
    Goncalves, Eduarda T.
    Homa, Liemi A.
    de Oliveira, Carlos Eduardo E.
    CANCER RESEARCH, 2023, 83 (05)
  • [36] IDENTIFYING ADHERENCE BARRIERS TO ORAL ENDOCRINE THERAPY (OET) AMONG BREAST CANCER PATIENTS
    Paranjpe, R.
    Trivedi, M.
    Abughosh, S.
    VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [37] Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients
    Woolpert, Kirsten M.
    Schmidt, Julie A.
    Ahern, Thomas P.
    Hjorth, Cathrine F.
    Farkas, Dora K.
    Ejlertsen, Bent
    Collin, Lindsay J.
    Lash, Timothy L.
    Cronin-Fenton, Deirdre P.
    BREAST CANCER RESEARCH, 2024, 26 (01) : 59
  • [38] Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients
    Arriola, Kimberly R. Jacob
    Mason, Tamara A.
    Bannon, Kari Ann
    Holmes, Carol
    Powell, Cecil Lamonte
    Horne, Kandra
    O'Regan, Ruth
    PATIENT EDUCATION AND COUNSELING, 2014, 95 (01) : 98 - 103
  • [39] Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
    David Cella
    Lesley J. Fallowfield
    Breast Cancer Research and Treatment, 2008, 107 : 167 - 180
  • [40] Outcome in patients treated with primary endocrine therapy and neoadjuvant endocrine therapy for breast cancer: A single centre experience
    Kim, B.
    Rajan, S.
    Mann, J.
    Achuthan, R.
    Turton, P.
    Verghese, E.
    Lansdown, M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S472 - S472
12345